• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝病毒清除后与乙型肝炎病毒感染相关的严重再生障碍性贫血缓解:拉米夫定的潜在作用

Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.

作者信息

Bozkaya Hakan, Yurdaydin Cihan, Törüner Murat, Arat Mutlu, Bozdayi A Mithat, Erekul Selim, Cinar Kubilay, Koç Haluk, Uzunalimoğlu Ozden

机构信息

Department of Gastroenterology, University of Ankara Medical School, Turkey.

出版信息

Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997.

DOI:10.1023/a:1016444611997
PMID:12184530
Abstract

Although viral hepatitis infection is known to be associated with aplastic anemia, a causal link between viral hepatitis and aplastic anemia has not been convincingly demonstrated. A case of hepatitis B-associated severe aplastic anemia is described which only partially responded to conventional immunosuppressive treatment but went into complete clinical remission after clearance of the hepatitis B virus. Disappearance of the hepatitis B virus occurred during lamivudine treatment and coincided with immune activation secondary to discontinuation of immunosuppressive therapy. This case was somewhat atypical in that a history of acute hepatitis preceding the aplastic anemia was absent. The observation made in this case report supports a cause-effect relationship between hepatitis B virus infection and aplastic anemia.

摘要

虽然已知病毒性肝炎感染与再生障碍性贫血有关,但病毒性肝炎与再生障碍性贫血之间的因果关系尚未得到令人信服的证实。本文描述了一例乙型肝炎相关的严重再生障碍性贫血病例,该病例对传统免疫抑制治疗仅部分有效,但在乙型肝炎病毒清除后实现了完全临床缓解。乙型肝炎病毒的清除发生在拉米夫定治疗期间,且与免疫抑制治疗中断继发的免疫激活同时出现。该病例有些不典型,因为在再生障碍性贫血之前没有急性肝炎病史。本病例报告中的观察结果支持乙型肝炎病毒感染与再生障碍性贫血之间的因果关系。

相似文献

1
Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.乙肝病毒清除后与乙型肝炎病毒感染相关的严重再生障碍性贫血缓解:拉米夫定的潜在作用
Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997.
2
Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.阿德福韦可有效促进异基因移植受者对供体来源乙肝病毒的免疫形成:一例病例报告。
Transplant Proc. 2013 Mar;45(2):833-4. doi: 10.1016/j.transproceed.2012.06.082.
3
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.免疫抑制疗法治疗血清阴性肝炎相关性再生障碍性贫血的疗效与安全性。
Drug Des Devel Ther. 2014 Sep 9;8:1299-305. doi: 10.2147/DDDT.S67908. eCollection 2014.
4
Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy.抗病毒治疗使急性乙型肝炎相关再生障碍性贫血得到缓解。
BMJ Case Rep. 2017 Oct 3;2017:bcr-2017-221503. doi: 10.1136/bcr-2017-221503.
5
[Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].再生障碍性贫血与病毒性肝炎(肝炎后再生障碍性贫血)
Ter Arkh. 1999;71(7):64-9.
6
Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report.尼日利亚儿童口服拉米夫定成功治疗乙型肝炎病毒相关性肾病综合征:一例报告。
J Trop Pediatr. 2012 Apr;58(2):157-8. doi: 10.1093/tropej/fmr046. Epub 2011 May 30.
7
Viral hepatitis B and aplastic anemia.
Tohoku J Exp Med. 1975 May;116(1):101-2. doi: 10.1620/tjem.116.101.
8
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.拉米夫定和泛昔洛韦治疗HIV合并急性乙型肝炎病毒感染及乙肝再激活患者
J Clin Gastroenterol. 2007 Feb;41(2):222-3. doi: 10.1097/01.mcg.0000212614.89584.32.
9
The Impact of Hepatitis on Clinical Outcomes for Pediatric Patients with Aplastic Anemia.肝炎对再生障碍性贫血儿科患者临床结局的影响。
J Pediatr. 2020 Dec;227:87-93.e2. doi: 10.1016/j.jpeds.2020.08.028. Epub 2020 Aug 14.
10
Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?长期使用拉米夫定治疗乙型肝炎相关性膜性肾病?
Kidney Int. 2006 Feb;69(4):776. doi: 10.1038/sj.ki.5000171.

引用本文的文献

1
Assessment of Hepatic Profile in Acquired Aplastic Anemia: An Experience From Pakistan.获得性再生障碍性贫血患者肝脏状况评估:来自巴基斯坦的经验
Cureus. 2022 Sep 12;14(9):e29079. doi: 10.7759/cureus.29079. eCollection 2022 Sep.
2
Multiple risks analysis for aplastic anemia in Zhejiang, China: A case-control study.中国浙江再生障碍性贫血的多重风险分析:一项病例对照研究。
Medicine (Baltimore). 2019 Feb;98(8):e14519. doi: 10.1097/MD.0000000000014519.
3
Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy.抗病毒治疗使急性乙型肝炎相关再生障碍性贫血得到缓解。

本文引用的文献

1
[Panmyelopathy following epidemic hepatitis].[流行性肝炎后的全骨髓病]
Wien Med Wochenschr. 1955 Jan 8;105(1):19-22.
2
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.肝炎相关性再生障碍性贫血中未知肝炎病毒的缺失及骨髓移植后的结局
Bone Marrow Transplant. 2001 Jan;27(2):183-90. doi: 10.1038/sj.bmt.1702749.
3
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.泼尼松龙预处理可增强慢性乙型肝炎患者的Th1反应及后续拉米夫定治疗的疗效。
BMJ Case Rep. 2017 Oct 3;2017:bcr-2017-221503. doi: 10.1136/bcr-2017-221503.
4
Transient pancytopenia preceding adult acute lymphoblastic leukemia with chromosomal abnormalities including the Philadelphia chromosome: A case report and review of the literature.伴有包括费城染色体在内的染色体异常的成人急性淋巴细胞白血病之前的短暂全血细胞减少症:一例报告并文献复习
Oncol Lett. 2015 Dec;10(6):3789-3792. doi: 10.3892/ol.2015.3766. Epub 2015 Sep 29.
5
Hepatitis associated aplastic anemia: a review.肝炎相关性再生障碍性贫血:综述。
Virol J. 2011 Feb 28;8:87. doi: 10.1186/1743-422X-8-87.
6
Hepatitis associated with aplastic anemia: do CD8(+) kupffer cells have a role in the pathogenesis?与再生障碍性贫血相关的肝炎:CD8(+) 库普弗细胞在发病机制中起作用吗?
Dig Dis Sci. 2007 Sep;52(9):2438-43. doi: 10.1007/s10620-006-9280-4. Epub 2007 Apr 19.
Hepatology. 2000 Sep;32(3):604-9. doi: 10.1053/jhep.2000.9717.
4
Improvement of anemia induced by parvovirus B19 in a patient with AIDS after combined antiretroviral therapy.一名艾滋病患者在接受联合抗逆转录病毒治疗后,细小病毒B19所致贫血的改善情况。
Mayo Clin Proc. 2000 Feb;75(2):215-6.
5
Lamivudine. A review of its therapeutic potential in chronic hepatitis B.拉米夫定。对其在慢性乙型肝炎治疗潜力的综述。
Drugs. 1999 Jul;58(1):101-41. doi: 10.2165/00003495-199958010-00015.
6
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.比较单独使用环孢素与抗胸腺细胞球蛋白联合环孢素治疗非重型再生障碍性贫血患者的前瞻性随机多中心研究:欧洲血液与骨髓移植(EBMT)重型再生障碍性贫血工作组的报告
Blood. 1999 Apr 1;93(7):2191-5.
7
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.拉米夫定治疗可恢复慢性乙型肝炎患者的T细胞反应性。
J Clin Invest. 1998 Sep 1;102(5):968-75. doi: 10.1172/JCI3731.
8
Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective.
Hepatology. 1997 Dec;26(6):1375-9. doi: 10.1053/jhep.1997.v26.ajhep0261375.
9
The pathophysiology of acquired aplastic anemia.获得性再生障碍性贫血的病理生理学。
N Engl J Med. 1997 May 8;336(19):1365-72. doi: 10.1056/NEJM199705083361906.
10
Hepatitis-associated aplastic anemia.肝炎相关性再生障碍性贫血
N Engl J Med. 1997 Apr 10;336(15):1059-64. doi: 10.1056/NEJM199704103361504.